Donor-specific anti-HLAAbs and graft failure in matched unrelated donor hematopoietic stem cell transplantation

Blood

Volumn 118, Issue 22, 2011, Pages 5957-5964

  Ciurea, Stefan O ^a   Thall, Peter F ^a   Wang, Xuemei ^a   Wang, Sa A ^a   Hu, Ying ^a   Cano, Pedro ^a   Aung, Fleur ^a   Rondon, Gabriela ^a   Molldrem, Jeffrey J ^a   Korbling, Martin ^a   Shpall, Elizabeth J ^a   De Lima, Marcos ^a   Champlin, Richard E ^a   Fernandez Vina, Marcelo ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; HLA ANTIBODY; MELPHALAN; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DONOR; FEMALE; FLUORESCENCE ANALYSIS; GENE LOCUS; GRAFT FAILURE; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; NONMYELOABLATIVE CONDITIONING; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; REDUCED INTENSITY CONDITIONING; SCHOOL CHILD; SENSITIZATION; SEX DIFFERENCE; WHOLE BODY RADIATION;

EID: 82155184523     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-06-362111     Document Type: Article

References (29)

1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354(17):1813-1826.
2. Sasazuki T, Juji T, Morishima Y, et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. N Engl J Med. 1998;339(17):1177-1185. (Pubitemid 28482126)
3. Weisdorf DJ, Anasetti C, Antin JH, et al. Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation. Blood. 2002;99(6):1971-1977. (Pubitemid 34525477)
4. Kiehl MG, Kraut L, Schwerdtfeger R, et al.: Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission. J Clin Oncol. 2004;22(14):2816-2825. (Pubitemid 41079899)
5. Hurley CK, Baxter Lowe LA, Logan B, et al. National Marrow Donor Program HLA-matching guidelines for unrelated marrow transplants. Biol Blood Marrow Transplant. 2003;9(10):610-615. (Pubitemid 38351780)
6. Lee S, Klein J, Haagenson M, et al. Highresolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood. 2007;110(13):4576-4583. (Pubitemid 351377826)
7. Davies SM, Kollman C, Anasetti C, et al. Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program. Blood. 2000;96(13):4096-4102.
8. Rubinstein PCarrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998;339(22):1565-1577.
9. Ciurea SO, Saliba R, Rondon G, et al. Reducedintensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT. Bone Marrow Transplant. 2010;45(3):429-436.
10. Ciurea SO, de Lima M, Cano P, et al. High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem cell transplantation. Transplantation. 2009;88(8):1019-1024.
11. Pei R, Lee JH, Shih NJ, Chen M, Terasaki PI. Single human leukocyte antigen flow cytometry beads for accurate identification of HLA antibody specificities. Transplantation. 2003;75(1):43-49. (Pubitemid 36139693)
12. Klitz W, Meiers M, Spellman S, et al. New HLA haplotype frequency reference standars: high resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans. Tissue Antigens. 2003;62(4):296-307. (Pubitemid 37204584)
13. Begovich AB, Moonsamy PV, Mack SJ, et al. Genetic variability and linkage disequilibrium within the HLA-DP region: analysis of 15 different populations. Tissue Antigens. 2001;57(5):424-439. (Pubitemid 32588548)
14. Fisher RA. On the interpretation of chi squared from contingency tables, and the calculation of P. J Royal Stat Soc. 1922;85:87-94.
15. Gelman A, Carlin JB, Stern HS, Rubin DB. Bayesian Data Analysis. 2nd ed. New York: Chapman and Hall; 2004.
16. Klein JP, Moeschberger ML. Survival Analysis: Techniques of Censored and Truncated Data. New York: Springer-Verlag; 2003.
17. Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS-a Bayesian modeling framework: concepts, structure, and extensibility. Statistics and Computing. 2000;10:325-37.
18. Patel R, Terasaki PI. Significance of positive crossmatch in kidney transplantation. N Engl J Med. 1969;280(14):735-739.
19. Suciu-Foca N, Reed E, Marboe C, et al. The role of anti-HLA antibodies in heart transplantation. Transplantation. 1991;51(3):716-724.
20. Held PJ, Kahan BD, Hunsicker LG, et al. The impact of HLA mismatches on the survival of first cadaveric kidney transplants. N Engl J Med. 1994;331(12):765-770. (Pubitemid 24284765)
21. Takanashi M, Atsuta A, Fujiwara K, et al. The impact of anti-HLA antibodies on unrelated cord blood transplantation. Blood. 2010;116(15):2839- 2846.
22. Spellman S, Bray R, Rosen-Bronson S, et al. The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure. Blood. 2010;115(13):2704-2708.
23. Fugier-Vivier IJ, Rezzoug F, Huang Y. Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment. J Exp Med. 2005;201(3):373-383. (Pubitemid 40229412)
24. Summers KL, Hock BD, McKenzie JL, Hart DN. Phenotypic characterization of five dendritic cell subsets in human tonsils. Am J Pathol. 2001; 159(1):285-295. (Pubitemid 33704213)
25. Hurley CK, Fernandez-Vina M, Hildebrand WH, et al. A high degree of HLA disparity arises from limited allelic diversity: analysis of 1775 unrelated bone marrow transplant donor-recipient pairs. Hum Immunol. 2007;68(1):30-40. (Pubitemid 46026882)
26. Fleischhauer K, Locatelli F, Zecca M, et al. Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with non-permissive HLA-DPB1 disparity in host-versus-graft direction. Blood. 2006;107(7):2984-2992.
27. Cano P, Fernández-Viña M. Two sequence dimorphisms of DPB1 define the immunodominant serologic epitopes of HLA-DP. Hum Immunol. 2009;70(10):836-843.
28. Xu H, Chilton PM, Tanner MK, et al. Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients. Blood. 2006;108(10):3611-3619.
29. Taylor PA, Ehrhardt MJ, Roforth MM, et al. Preformed antibody, not preformed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients. Blood. 2007;109(3):1307-1315. (Pubitemid 46220684)